Oncology Institute, Inc. 8-K

What Happened
Oncology Institute, Inc. (TOI) filed a Form 8-K on March 12, 2026 (Item 2.02) to announce its results of operations and financial condition for the fourth quarter and fiscal year ended December 31, 2025. The company furnished a press release with those quarterly and full-year earnings and related financial information as Exhibit 99.1 to the filing.

Key Details

• The 8-K was filed March 12, 2026 and covers Q4 and fiscal year ended December 31, 2025.
• The press release announcing the results is included as Exhibit 99.1.
• The filing includes an embedded Inline XBRL cover page interactive data file (Exhibit 104).
• The 8-K discloses the financial results and related information (Item 2.02) and furnishes the exhibits (Item 9.01).

Why It Matters
This filing gives investors the company’s latest quarterly and full-year earnings and financial-condition information (revenues, results, or other metrics disclosed in the press release). Retail investors should review the furnished press release and the company’s subsequent SEC filings for the specific revenue, earnings, cash flow, and guidance details needed to evaluate performance and investment implications.